ReNeu: A Pivotal, Phase IIb Trial of Mirdametinib in
Adults and Children With Symptomatic Neurofibromatosis
Type 1-Associated Plexiform Neurofibroma: https://t.co/JZW8HsFEgP @moert001#Neurofibromatosis
FDA approved nirogacestat (OGSIVEO, SpringWorks Therapeutics) for adult patients with progressing desmoid tumors who require systemic treatment. This is the first approved treatment for desmoid tumors.
https://t.co/yL68kdnnCS
#OCENewsBurst
Breaking: Today, the @US_FDA approved the first therapy for adults with #DesmoidTumors. We are thankful to the patients, physicians, advocates, and SpringWorkers who helped make this achievement possible. https://t.co/P5GWmQOU09